Literature DB >> 15728498

Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics.

Brett K Kaiser1, Fariba Barahmand-Pour, Wendy Paulsene, Scott Medley, Daniel E Geraghty, Roland K Strong.   

Abstract

The NKG2x/CD94 family of C-type lectin-like immunoreceptors (x = A, B, C, E, and H) mediates surveillance of MHC class Ia cell surface expression, often dysregulated during infection or tumorigenesis, by recognizing the MHC class Ib protein HLA-E that specifically presents peptides derived from class Ia leader sequences. In this study, we determine the affinities and interaction thermodynamics between three NKG2x/CD94 receptors (NKG2A, NKG2C, and NKG2E) and complexes of HLA-E with four representative peptides. Inhibitory NKG2A/CD94 and activating NKG2E/CD94 receptors bind HLA-E with indistinguishable affinities, but with significantly higher affinities than the activating NKG2C/CD94 receptor. Despite minor sequence differences, the peptide presented by HLA-E significantly influenced the affinities; HLA-E allelic differences had no effect. These results reveal important constraints on the integration of opposing activating and inhibitory signals driving NK cell effector functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728498     DOI: 10.4049/jimmunol.174.5.2878

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  65 in total

1.  NKG2C deletion is a risk factor of HIV infection.

Authors:  Rachel Thomas; Hui Zhi Low; Katja Kniesch; Roland Jacobs; Reinhold E Schmidt; Torsten Witte
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-03       Impact factor: 2.205

Review 2.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

3.  HLA-F is a surface marker on activated lymphocytes.

Authors:  Ni Lee; Akiko Ishitani; Daniel E Geraghty
Journal:  Eur J Immunol       Date:  2010-08       Impact factor: 5.532

Review 4.  Harnessing adaptive natural killer cells in cancer immunotherapy.

Authors:  Lisa L Liu; Aline Pfefferle; Vincent Oei Yi Sheng; Andreas T Björklund; Vivien Béziat; Jodie P Goodridge; Karl-Johan Malmberg
Journal:  Mol Oncol       Date:  2015-10-20       Impact factor: 6.603

5.  NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines.

Authors:  Nadine van Montfoort; Linda Borst; Michael J Korrer; Marjolein Sluijter; Koen A Marijt; Saskia J Santegoets; Vanessa J van Ham; Ilina Ehsan; Pornpimol Charoentong; Pascale André; Nicolai Wagtmann; Marij J P Welters; Young J Kim; Sytse J Piersma; Sjoerd H van der Burg; Thorbald van Hall
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

6.  HLA-E, HLA-F, and HLA-G polymorphism: genomic sequence defines haplotype structure and variation spanning the nonclassical class I genes.

Authors:  Chul-Woo Pyo; Luke M Williams; Yuki Moore; Hironobu Hyodo; Shuying Sue Li; Lue Ping Zhao; Noriko Sageshima; Akiko Ishitani; Daniel E Geraghty
Journal:  Immunogenetics       Date:  2006-03-29       Impact factor: 2.846

Review 7.  The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance.

Authors:  Francisco Borrego; Madhan Masilamani; Alina I Marusina; Xiaobin Tang; John E Coligan
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

8.  Pas de deux: natural killer receptors and MHC class I ligands in primates.

Authors:  Walter Lutz
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

9.  Human NKG2E is expressed and forms an intracytoplasmic complex with CD94 and DAP12.

Authors:  Gerasim A Orbelyan; Fangming Tang; Benjamin Sally; Jason Solus; Bertrand Meresse; Cezary Ciszewski; Jean-Christophe Grenier; Luis B Barreiro; Lewis L Lanier; Bana Jabri
Journal:  J Immunol       Date:  2014-06-16       Impact factor: 5.422

10.  Heterogeneity in the CD200R paired receptor family.

Authors:  Munir Akkaya; A Neil Barclay
Journal:  Immunogenetics       Date:  2009-12-05       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.